Abstract
Reformulation of anti-tuberculosis drugs into dry powder particles for inhalation is a novel strategy that aims to increase therapeutically relevant drug concentration at the primary site of infection and to limit associated toxicity by avoiding or minimizing first-pass metabolism. Development of such formulations ultimately requires quantified evidence of the deposition, absorption and clearance of inhaled active ingredient. In this context, we investigated the potential of radiolabelling particles with 153Sm for subsequent gamma imaging, and to demonstrate that the technique is not detrimental to particle integrity. The study showed that the known properties of spray dried leucine (a major constituent of an inhalable capreomycin formulation) for deep lung inhalation are not altered by incorporation of samarium-chloride (SmCl3) at 10% (w/w), or by neutron activation of particles that include stable 152SmCl3. SEM imaging indicated that the particle morphology was homogeneous and spherical after neutron activation. No discoloration of the samples or a change in dry powder particle size at 5 minutes occurred, provided the optimized formulations were activated for only 1 minute. Activation for 1 minute still provides enough 153Sm for imaging purposes.
Keywords: Gamma imaging, 153Sm radiolabel, spray dried powder particles, pulmonary drug delivery, tuberculosis, leucine, capreomycin, human immunodeficiency virus (HIV), multi-drug resistance, Neutron Activation, Chemical, Reagents, chromatography (HPLC), Samarium Formulation, homogeneous.
Drug Delivery Letters
Title:Characterization of Radiolabeled Dry Powder Leucine, a Constituent of Inhalable Capreomycin
Volume: 2 Issue: 3
Author(s): Lindie Venter, Judith Wagener, P. Bernard Fourie and Jan Rijn Zeevaart
Affiliation:
Keywords: Gamma imaging, 153Sm radiolabel, spray dried powder particles, pulmonary drug delivery, tuberculosis, leucine, capreomycin, human immunodeficiency virus (HIV), multi-drug resistance, Neutron Activation, Chemical, Reagents, chromatography (HPLC), Samarium Formulation, homogeneous.
Abstract: Reformulation of anti-tuberculosis drugs into dry powder particles for inhalation is a novel strategy that aims to increase therapeutically relevant drug concentration at the primary site of infection and to limit associated toxicity by avoiding or minimizing first-pass metabolism. Development of such formulations ultimately requires quantified evidence of the deposition, absorption and clearance of inhaled active ingredient. In this context, we investigated the potential of radiolabelling particles with 153Sm for subsequent gamma imaging, and to demonstrate that the technique is not detrimental to particle integrity. The study showed that the known properties of spray dried leucine (a major constituent of an inhalable capreomycin formulation) for deep lung inhalation are not altered by incorporation of samarium-chloride (SmCl3) at 10% (w/w), or by neutron activation of particles that include stable 152SmCl3. SEM imaging indicated that the particle morphology was homogeneous and spherical after neutron activation. No discoloration of the samples or a change in dry powder particle size at 5 minutes occurred, provided the optimized formulations were activated for only 1 minute. Activation for 1 minute still provides enough 153Sm for imaging purposes.
Export Options
About this article
Cite this article as:
Venter Lindie, Wagener Judith, Bernard Fourie P. and Rijn Zeevaart Jan, Characterization of Radiolabeled Dry Powder Leucine, a Constituent of Inhalable Capreomycin, Drug Delivery Letters 2012; 2 (3) . https://dx.doi.org/10.2174/2210304x11202030155
DOI https://dx.doi.org/10.2174/2210304x11202030155 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Determining Partition Coefficient (Log P), Distribution Coefficient (Log D) and Ionization Constant (pKa) in Early Drug Discovery
Combinatorial Chemistry & High Throughput Screening Susceptibility of Periodontopathogenic and Cariogenic Bacteria to Defensins and Potential Therapeutic Use of Defensins in Oral Diseases
Current Pharmaceutical Design NMR Assisted Antimicrobial Peptide Designing: Structure Based Modifications and Functional Correlation of a Designed Peptide VG16KRKP
Current Medicinal Chemistry Cofactor Biosynthetic Pathways in Mycobacterium tuberculosis as Potential Drug Targets
Current Respiratory Medicine Reviews Detection of the Incidence of Infections and Acute Biochemical Changes in Diffused Large B-Cell Lymphoma Patients Treated with Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (CHOP) with and without Rituximab
Current Drug Safety Benzothiazol Clubbed Imidazol-4-ones as Anti-fungal, Anti-tubercular and Anti-HIV-1 Agents: Their Synthesis and Molecular Docking Study
Letters in Drug Design & Discovery The Parent-into-F1 Model of Graft-vs-Host Disease as a Model of In Vivo T Cell Function and Immunomodulation
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Medicinal Chemistry Discoveries among 1,3,5-Triazines: Recent Advances (2000-2013) as Antimicrobial, Anti-TB, Anti-HIV and Antimalarials
Mini-Reviews in Medicinal Chemistry Opportunities and Challenges for Host-Directed Therapies in Tuberculosis
Current Pharmaceutical Design Local Renin-Angiotensin II Systems, Angiotensin-Converting Enzyme and its Homologue ACE2: Their Potential Role in the Pathogenesis of Chronic Obstructive Pulmonary Diseases, Pulmonary Hypertension and Acute Respiratory Distress Syndrome
Current Medicinal Chemistry Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
Reviews on Recent Clinical Trials Lead Molecules for Targeted Urease Inhibition: An Updated Review from 2010 -2018
Current Protein & Peptide Science Antifungal Azole Derivatives and their Pharmacological Potential: Prospects & Retrospects
The Natural Products Journal Recent Progress of Molecular Docking Simulations Applied to Development of Drugs
Current Bioinformatics The Evolution of Clostridium difficile Infection in Cancer Patients: Epidemiology, Pathophysiology, and Guidelines for Prevention and Management
Recent Patents on Anti-Infective Drug Discovery HIV Genetic Diversity: Biological and Public Health Consequences
Current HIV Research Editorial
Recent Patents on Inflammation & Allergy Drug Discovery Antibiotic use Evaluation in Hospitalized Pediatric Patients with Respiratory Tract Infections: A Retrospective Chart Review Study
Current Drug Safety A Review of Computational Identification of Protein Post-Translational Modifications
Mini-Reviews in Organic Chemistry Premature Ageing Prevention: Limitations and Perspectives of Pharmacological Interventions
Current Drug Targets